Shortened Regimens for Drug-susceptible Pulmonary Tuberculosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2016
The purpose of the study is to evaluate the safety and efficacy of two shortened regimens for newly diagnosed smear positive drug susceptible pulmonary tuberculosis in comparison to World Health Organization recommended standard 6-month regimen.
Epistemonikos ID: 962646c582ca7c21f05947e77fad0e3ae7ab1812
First added on: May 17, 2024